Janus Henderson Group
RAPT

Janus Henderson Group’s RAPT Therapeutics RAPT Stock Holding History

Janus Henderson Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000
Closed -$143K – 2568
2024
Q1 		$143K Hold
2,000
– – ﹤0.01% 2476
2023
Q4 		$398K Sell
2,000
-2
-0.1% -$248 ﹤0.01% 2094
2023
Q3 		$266K Buy
2,002
+1
+0% +$163 ﹤0.01% 2247
2023
Q2 		$299K Sell
2,001
-4
-0.2% -$623 ﹤0.01% 2249
2023
Q1 		$294K Buy
+2,005
New +$406K ﹤0.01% 2295

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group's RAPT Position: Q2 2024 in Review

Janus Henderson Group sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 2,000 shares — an estimated $143K sold.

Janus Henderson Group first reported a position in RAPT in Q1 2023 and held it in 5 quarters. The position peaked at $398K in Q4 2023. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • Janus Henderson Group reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 2,000 RAPT Therapeutics shares in Q2 2024, an estimated $143K.
  • Janus Henderson Group first reported a position in RAPT Therapeutics in Q1 2023 and held it in 5 quarters.
  • Janus Henderson Group's RAPT Therapeutics position peaked at $398K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.